News

To combat rising maternal mortality, researchers at Saint Luke's Mid America Heart Institute and UMKC are leading a first of its kind study to create better care for moms with heart conditions during pregnancy.

The four-year observational study will research U.S. pregnant people with cardiovascular disease to better understand and combat maternal mortality and morbidity.

Dr. Tim Pluard talks about an exciting expansion that will make cancer care more accessible to Kansas City’s growing Northland community.

Feeling “off” turned into a critical situation within moments when Stacee suffered a ruptured brain aneurysm that led to a hemorrhagic stroke.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Dr. Tim Pluard, medical director of Saint Luke’s Koontz Center for Advanced Breast Cancer and of Saint Luke’s Cancer Institute, talks about innovative treatment options for breast cancer and clinical trials offered at Saint Luke’s.

We’re talking about how younger women and men can monitor for breast cancer and recent updates in screening guidelines.

This week during Breast Cancer Awareness Month, we’re talking about metastatic breast cancer and Saint Luke’s Koontz Center—the region’s only center dedicated and designed specifically for these patients.

In the past, many women born with a heart condition were told they would not be able to birth children safely.

An elementary school music teacher and jazz musician, 54-year-old Lisa was initially diagnosed with high blood pressure—the number one killer of women—in her early 30s. It is often called “the silent killer” because most who have it don’t experience any symptoms. Lisa was on blood pressure medication but had stopped taking it because she experienced side effects. She put off seeing her doctor about it for several months.